Quest Diagnostics
(NYSE) DGX
Quest Diagnostics Financials at a Glance
Market Cap
$21.77B
Revenue (TTM)
$11.04B
Net Income (TTM)
$992.00M
EPS (TTM)
$8.76
P/E Ratio
22.61
Dividend
$3.20
Beta (Volatility)
0.38 (Low)
Dividend
$3.20
Beta (Volatility)
0.38 (Low)
Price
$195.64
Volume
26,627
Open
$196.38
Price
$195.64
Volume
26,627
Open
$196.38
Previous Close
$195.64
Daily Range
$194.60 - $197.76
52-Week Range
$157.20 - $213.50
Dividend
$3.20
Beta (Volatility)
0.38 (Low)
Price
$195.64
Volume
26,627
Open
$196.38
Previous Close
$195.64
Daily Range
$194.60 - $197.76
52-Week Range
$157.20 - $213.50
DGX News
DGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quest Diagnostics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
57,000
CEO
James E. Davis
Website
www.questdiagnostics.comHeadquarters
Secaucus, NJ 07094, US
DGX Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
14%
Net Income Margin
9%
Return on Equity
14%
Return on Capital
11%
Return on Assets
6%
Earnings Yield
4.42%
Dividend Yield
0.02%
Payout Ratio
35.58%
Stock Overview
Market Cap
$21.77B
Shares Outstanding
109.87M
Volume
26.63K
Short Interest
0.00%
Avg. Volume
980.39K
Financials (TTM)
Gross Profit
$3.52B
Operating Income
$1.60B
EBITDA
$2.19B
Operating Cash Flow
$1.89B
Capital Expenditure
$527.00M
Free Cash Flow
$1.36B
Cash & ST Invst.
$420.00M
Total Debt
$6.92B
Quest Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.81B
+7.1%
Gross Profit
$914.00M
+6.5%
Gross Margin
32.57%
N/A
Market Cap
$21.77B
N/A
Market Cap/Employee
$395.82K
N/A
Employees
55,000
N/A
Net Income
$245.00M
+10.4%
EBITDA
$401.00M
-20.9%
Quarterly Fundamentals
Net Cash
$6.50B
-1.9%
Accounts Receivable
$1.41B
+8.0%
Inventory
$189.00M
+0.5%
Long Term Debt
$6.24B
+1.5%
Short Term Debt
$678.00M
-12.5%
Return on Assets
6.11%
N/A
Return on Invested Capital
11.19%
N/A
Free Cash Flow
$307.00M
-10.0%
Operating Cash Flow
$465.00M
+0.2%